Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

10.1097/JTO.0b013e3181913e28

Saved in:

Bibliographic Details
Main Authors:	Lim, E.H., Chang, A., Tan, P., Zhang, S.-L., Li, J.-L., Yap, W.-S., Ng, A., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M.
Other Authors:	SURGERY
Format:	Article
Published:	2011
Subjects:	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/24184
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-24184
record_format	dspace
spelling	sg-nus-scholar.10635-241842023-10-30T08:43:08Z Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. SURGERY MEDICINE DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE DIAGNOSTIC RADIOLOGY DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification 10.1097/JTO.0b013e3181913e28 Journal of Thoracic Oncology 4 1 12-21 2011-07-19T10:13:21Z 2011-07-19T10:13:21Z 2009 Article Lim, E.H., Chang, A., Tan, P., Zhang, S.-L., Li, J.-L., Yap, W.-S., Ng, A., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M. (2009). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 4 (1) : 12-21. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181913e28 15560864 15561380 http://scholarbank.nus.edu.sg/handle/10635/24184 000262196500003 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
spellingShingle	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
description	10.1097/JTO.0b013e3181913e28
author2	SURGERY
author_facet	SURGERY Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M.
format	Article
author	Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M.
author_sort	Lim, E.H.
title	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_short	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_full	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_fullStr	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_full_unstemmed	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_sort	using whole genome amplification (wga) of low-volume biopsies to assess the prognostic role of egfr, kras, p53, and cmet mutations in advanced-stage non-small cell lung cancer (nsclc)
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/24184
_version_	1781410271985664000

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

Similar Items